IP Library › Assignment 027906/0457
Patent Assignment
Reel/Frame 027906/0457

Patent Security Agreement Supplement

Recorded: 2012-03-22 Received: 2012-03-22 Pages: 11
Assignor
ACTAVIS GROUP PTC EHF.
Executed: 2011-11-18
Assignee
DEUTSCHE BANK AG, LONDON BRANCH, AS SECURITY AGENT
1 GREAT WINCHESTER STREET, LONDON, GBX, EC2N 2DB, UNITED KINGDOM
Covered Properties (41)
Novel Solid State Forms of Ranolazine Salts
Application: 13/063,029 →
Laquinimod or a Pharmaceutically Acceptable Salt Thereof
Application: 13/133,994 →
Highly Pure Ranolazine or a Pharmaceutically Acceptable Salt Thereof
Application: 13/124,479 →
Process for Preparing Varenicline, Varenicline Intermediates, and Pharmaceutically Acceptable Salts Thereof
Application: 13/060,755 →
Process for Preparing Pregabalin
Application: 12/995,782 →
Unsaturated Cinacalcet Salts and Processes for Preparing Cinacalcet Hydrochloride
Application: 13/057,796 →
Novel Solid State Forms of Laquinimod and Its Sodium Salt
Application: 13/001,715 →
Fesoterodine Substantially Free of Dehydroxy Impurity
Application: 13/055,075 →
Substantially Pure Deferasirox and Processes for the Preparation Thereof
Application: 12/995,795 →
Process for Preparing Quinoline-3-Carboxamide Derivatives
Application: 12/989,796 →
Rasagiline Mesylate Particles and Process for the Preparation Thereof
Application: 12/935,363 →
Solid State Forms of Deferasirox Salts and Process for the Preparation Thereof
Application: 12/988,836 →
Novel Mandelate Salt of Fesoterodine
Application: 12/936,241 →
Solid State Forms of Fesoterodine Intermediates
Application: 12/949,102 →
Novel Polymorphs of Bosentan
Application: 12/682,112 →
Amorphous Arformoterol L-(+)-Tartrate
Application: 12/919,028 →
Solid State Forms of Tapentadol Salts
Application: 12/886,680 →
Solid Forms of (¿)-O-Desmethylvenlafaxine Salts
Application: 12/739,163 →
Process for the Preparation of Risedronate Sodium
Application: 12/599,980 →
Amorphous Fesoterodine Fumarate
Application: 12/680,848 →
Novel Hemioxalate Salt of Eletriptan
Application: 12/808,762 →
Amorphous Coprecipitates of Atorvastatin Pharmaceutically Acceptable Salts
Application: 12/669,543 →
Substantially Pure Imatinib or a Pharmaceutically Acceptable Salt Thereof
Application: 12/782,234 →
Quetiapine Salts and Their Polymorphs
Application: 12/599,085 →
Process for the Preparation of Fesoterodine
Application: 12/678,845 →
Amorphous Form of Tapentadol Hydrochloride
Application: 12/769,013 →
Novel Polymorphs of Darifenacin Free Base and its Hydrobromide Salt
Application: 12/663,558 →
Repaglinide Substantially Free of Dimer Impurity
Application: 12/663,106 →
Process for the Preparation of Alfuzosin and Salts Thereof
Application: 12/598,839 →
Photovoltaic Cell Based on Zinc Oxide Nanorods and Method for Making the Same
Application: 12/668,443 →
Process for Preparing Irbesartan
Application: 12/530,039 →
Process for Preparation of 9-Hydroxy-3-(2-Chloroethyl)-2-Methyl-4H-Pyrido[1,2-a]Pyrimidin-4-One Hydrochloride
Application: 12/522,282 →
O-desmethylvenlafaxine Cocrystals
Application: 12/415,052 →
Controlled-Release Galantamine Formulations
Oral Dosage Formulations and Methods of Preparing the Same
Paroxetine Formulations
Atomoxetine Formulations
Donepezil Formulations
Galantamine Formulations
Galantamine Formulations
Deployment System for an Expandable Device
Application: 10/892,934 →